Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 1,627,837 | 1,538,271 | 1,524,485 | 1,515,107 | 1,413,244 |
| Cost of Goods | 203,101 | 186,182 | 184,520 | 162,497 | 185,054 |
| Gross Profit | 1,424,737 | 1,352,089 | 1,339,965 | 1,352,610 | 1,228,190 |
| Operating Expenses | 679,035 | 680,030 | 622,452 | 632,883 | 676,845 |
| Operating Income | 745,802 | 672,241 | 718,033 | 720,224 | 551,399 |
| Interest Expense | 16,337 | 13,856 | 13,871 | 14,136 | 14,247 |
| Other Income | 159,260 | 87,486 | 120,608 | -48,554 | 139,779 |
| Pre-tax Income | 888,725 | 745,871 | 824,770 | 657,534 | 676,931 |
| Income Tax | 284,482 | 78,437 | -12,500 | 54,781 | 93,707 |
| Net Income Continuous | 604,243 | 667,434 | 837,270 | 602,753 | 583,224 |
| Net Income | $604,243 | $667,434 | $837,270 | $602,753 | $583,224 |
| EPS Basic Total Ops | 2.34 | 2.56 | 3.22 | 2.32 | 2.27 |
| EPS Basic Continuous Ops | 2.33 | 2.56 | 3.22 | 2.32 | 2.27 |
| EPS Diluted Total Ops | 2.29 | 2.53 | 3.18 | 2.29 | 2.23 |
| EPS Diluted Continuous Ops | 2.30 | 2.53 | 3.18 | 2.29 | 2.23 |
| EBITDA(a) | $775,142 | $698,883 | $744,730 | $747,045 | $577,614 |